Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AFYA
stocks logo

AFYA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
921.60M
+8.55%
2.026
-3.53%
1.01B
+7.37%
3.108
-2.88%
986.26M
+7.27%
2.260
-0.45%
Estimates Revision
The market is revising Downward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by -0.36% over the past three months. During the same period, the stock price has changed by 1.06%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.36%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.45%
In Past 3 Month
Stock Price
Go Up
up Image
+1.06%
In Past 3 Month
Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.33 USD with a low forecast of 17.50 USD and a high forecast of 24.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.33 USD with a low forecast of 17.50 USD and a high forecast of 24.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 15.200
sliders
Low
17.50
Averages
20.33
High
24.50
Current: 15.200
sliders
Low
17.50
Averages
20.33
High
24.50
JPMorgan
Neutral -> Overweight
upgrade
2025-09-08
Reason
JPMorgan
Price Target
2025-09-08
upgrade
Neutral -> Overweight
Reason
JPMorgan upgraded Afya to Overweight from Neutral with a price target of $24.50, up from $23.50. The company's focus on medical education ?provides superior consistency and visibility," the analyst tells investors in a research note. The firm says Afya is one of the most consistent players in the Brazilian education industry, with high visibility and never missing guidance. It views the stock as a "solid pick for the risk-averse."
UBS
Andre Salles
Neutral -> Buy
upgrade
$19
2025-09-08
Reason
UBS
Andre Salles
Price Target
$19
2025-09-08
upgrade
Neutral -> Buy
Reason
UBS analyst Andre Salles upgraded Afya to Buy from Neutral with a price target of $19, down from $19.50. JPMorgan also upgrade the stock this morning. UBS sees "strong momentum" for the company's business, with "healthy" demand for medical courses. Meanwhile, Afya's cost cutting initiatives should maintain its EBITDA margin at a fairly stable 45%, the analyst tells investors in a research note. The firm believes current share levels offer an opportunity to buy a "high quality, low leveraged and high return name" in the Brazil education industry.
Morgan Stanley
Underweight -> Equal Weight
upgrade
$19
2025-08-05
Reason
Morgan Stanley
Price Target
$19
2025-08-05
upgrade
Underweight -> Equal Weight
Reason
Morgan Stanley upgraded Afya to Equal Weight from Underweight with a price target of $17.50, down from $19, as part of a broader research note on Brazil Education Services. The new sector regulation will both reshape industry structure and reset economic equilibrium, the analyst tells investors in a research note. Despite long-term medical school risks, the firm sees strong short-term earnings and a narrower valuation gap relative to peers, Morgan Stanley added.
Citi
Sell -> Neutral
upgrade
$16 -> $14
2025-07-29
Reason
Citi
Price Target
$16 -> $14
2025-07-29
upgrade
Sell -> Neutral
Reason
Citi upgraded Afya to Neutral from Sell with a price target of $14, down from $16. The firm says the company's risks are better priced into the shares following Afya's underperformance year-to-date relative to its Brazilian peers. The firm cites valuation for the upgrade despite dropping the target on reduced earnings assumptions.
UBS
Neutral
maintain
2025-06-12
Reason
UBS
Price Target
2025-06-12
maintain
Neutral
Reason
UBS raised the firm's price target on Afya to $19.50 from $17.50 and keeps a Neutral rating on the shares. Positive momentum on growth and margins seems fairly priced in, the analyst tells investors in a research note.
Morgan Stanley
Mauricio Cepeda
Hold
to
Sell
Downgrades
$19 → $17
2025-03-11
Reason
Morgan Stanley
Mauricio Cepeda
Price Target
$19 → $17
2025-03-11
Downgrades
Hold
to
Sell
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Afya Ltd (AFYA.O) is 8.18, compared to its 5-year average forward P/E of 14.15. For a more detailed relative valuation and DCF analysis to assess Afya Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
14.15
Current PE
8.18
Overvalued PE
20.14
Undervalued PE
8.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
8.57
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.70
Undervalued EV/EBITDA
5.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.11
Current PS
0.00
Overvalued PS
4.66
Undervalued PS
1.55
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

AFYA News & Events

Events Timeline

(ET)
2025-11-12
18:14:48
Afya announces Q3 adjusted EBITDA of R$398.9M, a 14.6% increase year-over-year
select
2025-11-07 (ET)
2025-11-07
08:54:49
Afya Reveals Expansion of Medical Seats at ITPAC Porto Nacional
select
2025-08-13 (ET)
2025-08-13
18:22:29
Afya still sees 2025 revenue R$3.67B-R$3.77B
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-13NASDAQ.COM
Afya (AFYA) Exceeds Earnings Expectations in Q3

  • Earnings Performance: Afya (AFYA) reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.32, marking an 18.75% earnings surprise. The company has surpassed consensus EPS estimates three times in the last four quarters.

  • Revenue Insights: The company generated revenues of $170.44 million for the quarter, slightly missing the consensus estimate by 0.16%, but showing growth from $151.71 million a year ago. Afya has topped revenue estimates twice in the last four quarters.

  • Stock Outlook: Afya shares have declined by 9.1% year-to-date, underperforming the S&P 500's 16.4% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

  • Industry Context: The Schools industry, to which Afya belongs, is ranked in the bottom 32% of Zacks industries, suggesting potential challenges ahead. Investors are advised to monitor earnings estimate revisions and industry outlooks for future stock performance.

[object Object]
Preview
9.5
11-13Yahoo Finance
Afya Limited Reports Financial Results for Q3 and First Nine Months of 2025

  • Financial Performance: Afya Limited reported a 10.4% year-over-year revenue increase in Q3 2025, reaching R$928.5 million, with a notable 14.6% rise in Adjusted EBITDA to R$398.9 million and a net income growth of 28.4% to R$159.4 million.

  • Operational Highlights: The company achieved a strong Adjusted EBITDA margin of 43.0%, driven by growth across its three segments: Undergraduate, Continuing Education, and Medical Practice Solutions, while maintaining a solid cash position of R$996.8 million.

  • Strategic Initiatives: Afya is focused on enhancing its ecosystem through AI-enabled solutions and expanding its medical school capacity, reaffirming its 2025 guidance for revenue between R$3.67 billion and R$3.77 billion.

  • Capital Management: The company successfully issued R$1.5 billion in commercial notes to strengthen its capital structure, repurchased shares, and reduced net debt significantly, reflecting a disciplined approach to capital allocation and liability management.

[object Object]
Preview
5.0
11-07Newsfilter
Afya Limited Reveals Expansion of Medical Seats at AFYA Faculdade de Ciências Médicas Bragança

  • Increase in Medical Seats: Afya Limited has received authorization to increase medical seats at ITPAC Porto Nacional in Bragança, Pará, by 100, bringing the total to 150 seats on this campus.

  • Total Approved Seats: With this increase, Afya now has a total of 3,753 approved medical school seats across its institutions, highlighting its significant presence in Brazil's medical education sector.

  • Commitment to Quality Education: The expansion reflects Afya's commitment to providing quality medical education and its role as a leading medical education group in Brazil.

  • Comprehensive Ecosystem: Afya offers a physician-centric ecosystem that supports students and physicians throughout their careers, from medical school to residency preparation and continuing education.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Afya Ltd (AFYA) stock price today?

The current price of AFYA is 15.2 USD — it has increased 0.13 % in the last trading day.

arrow icon

What is Afya Ltd (AFYA)'s business?

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

arrow icon

What is the price predicton of AFYA Stock?

Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.33 USD with a low forecast of 17.50 USD and a high forecast of 24.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Afya Ltd (AFYA)'s revenue for the last quarter?

Afya Ltd revenue for the last quarter amounts to 928.51M USD, increased 10.38 % YoY.

arrow icon

What is Afya Ltd (AFYA)'s earnings per share (EPS) for the last quarter?

Afya Ltd. EPS for the last quarter amounts to 1.70 USD, increased 29.77 % YoY.

arrow icon

What changes have occurred in the market's expectations for Afya Ltd (AFYA)'s fundamentals?

The market is revising Downward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by -0.36% over the past three months. During the same period, the stock price has changed by 1.06%.
arrow icon

How many employees does Afya Ltd (AFYA). have?

Afya Ltd (AFYA) has 9717 emplpoyees as of December 05 2025.

arrow icon

What is Afya Ltd (AFYA) market cap?

Today AFYA has the market capitalization of 1.42B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free